Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-15-000922
Filing Date
2015-07-08
Accepted
2015-07-08 17:46:19
Documents
1
Period of Report
2015-07-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8636
  Complete submission text file 0000899243-15-000922.txt   11226
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address
ISALY SAMUEL D (Reporting) CIK: 0001055949 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37471 | Film No.: 15980003

Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Reporting) CIK: 0001055951 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-37471 | Film No.: 15980005

Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 212-749-6400
OrbiMed Capital GP III LLC (Reporting) CIK: 0001432241 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37471 | Film No.: 15980004

Mailing Address LISE-MEITNER-STRASSE 30 FREISING-WEIHENSTEPHAN 2M 85354
Business Address LISE-MEITNER-STRASSE 30 FREISING-WEIHENSTEPHAN 2M 85354 49 81 6114 11400
PIERIS PHARMACEUTICALS, INC. (Issuer) CIK: 0001583648 (see all company filings)

EIN.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research